Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Med Inc (NQ: NMRD )

2.560 +0.010 (+0.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,495
Open 2.800
Bid (Size) 1.020 (1)
Ask (Size) 3.000 (10)
Prev. Close 2.550
Today's Range 2.559 - 2.800
52wk Range 2.150 - 17.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate in H.C. Wainwright Global Hybrid Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) UK licensee, MySugarWatch, Begins Direct-to-Consumer Campaign in Daily Mail
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-45.06%
-45.06%
1 Month
-30.43%
-30.43%
3 Month
-33.85%
-33.85%
6 Month
-45.30%
-45.30%
1 Year
-78.47%
-78.47%

More News

Read More
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R)
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Planet MicroCap Showcase 2022
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical's (NASDAQ: NMRD) Technologies Stand Distinct
Via Benzinga
Nemaura Medical’s (NASDAQ: NMRD) Technologies Stand Distinct
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
Via Benzinga
Nemaura To Participate At Maxim Group Virtual Growth Conference
Via Benzinga
Nemaura (NASDAQ: NMRD) to Participate at Maxim Group Virtual Growth Conference
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Maxim Group 2022 Virtual Growth Conference
Via Investor Brand Network
Nemaura Medical Bringing Valuable AI-Powered Insights To Diabetes Market
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
Nemaura Enters Commercialization Phase Of Development
Via Benzinga
Nemaura (NASDAQ: NMRD) Enters Commercialization Phase of Corporate Development
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues
Via Investor Brand Network
Nemaura Medical's sugarBEAT(R) CGM Device Met With Early Success
Via Benzinga
Nemaura Medical’s (NASDAQ: NMRD) sugarBEAT(R) CGM Device Met with Early Success
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success
Via Investor Brand Network
Nemaura Medical Recognized As Innovator Of The Year
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Recognized as Innovator of the Year
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Recognized as Innovator of the Year, Awarded Top Honors for Innovation in MedTech, Life Sciences
Via Investor Brand Network
Nemaura Medical Producing What Was Thought To Be Implausible
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.